MCID: ANG003
MIFTS: 13

Angelucci's Syndrome

Categories: Eye diseases

Aliases & Classifications for Angelucci's Syndrome

MalaCards integrated aliases for Angelucci's Syndrome:

Name: Angelucci's Syndrome 12
Acute Atopic Conjunctivitis 12 69
Angelucci Syndrome 12

Classifications:



External Ids:

Disease Ontology 12 DOID:11203
ICD10 32 H10.1
ICD9CM 34 372.05
NCIt 46 C34353
SNOMED-CT 64 193863004 67678004
UMLS 69 C0001309

Summaries for Angelucci's Syndrome

MalaCards based summary : Angelucci's Syndrome, is also known as acute atopic conjunctivitis. The drugs Alcaftadine and Histamine have been mentioned in the context of this disorder. Affiliated tissues include eye.

Related Diseases for Angelucci's Syndrome

Symptoms & Phenotypes for Angelucci's Syndrome

Drugs & Therapeutics for Angelucci's Syndrome

Drugs for Angelucci's Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 36)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Alcaftadine Approved Phase 4 147084-10-4 19371515
2
Histamine Approved, Investigational Phase 4,Phase 3,Phase 2 51-45-6, 75614-87-8 774
3 Analgesics Phase 4,Phase 3,Phase 2
4 Analgesics, Non-Narcotic Phase 4,Phase 3,Phase 2
5 Anti-Allergic Agents Phase 4,Phase 3,Phase 2
6 Anticoagulants Phase 4
7 Anti-Inflammatory Agents Phase 4,Phase 3,Phase 2
8 Anti-Inflammatory Agents, Non-Steroidal Phase 4,Phase 3,Phase 2
9 Antirheumatic Agents Phase 4,Phase 3,Phase 2
10 Blood Substitutes Phase 4
11 Dextrans Phase 4
12 Histamine Antagonists Phase 4,Phase 3,Phase 2
13 Histamine H1 Antagonists Phase 4,Phase 3,Phase 2
14 Histamine H1 Antagonists, Non-Sedating Phase 4,Phase 3,Phase 2
15
Histamine Phosphate Phase 4,Phase 3,Phase 2 51-74-1 65513
16 Lubricant Eye Drops Phase 4,Phase 2
17 Neurotransmitter Agents Phase 4,Phase 3,Phase 2
18 Olopatadine Hydrochloride Phase 4,Phase 3,Phase 2
19 Ophthalmic Solutions Phase 4,Phase 2,Phase 3
20 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2
21 Pharmaceutical Solutions Phase 4,Phase 2,Phase 3
22 Plasma Substitutes Phase 4
23
Ephedrine Approved Phase 3 299-42-3 9294
24
Ketotifen Approved Phase 3,Phase 2 34580-13-7, 34580-14-8 3827
25
Naphazoline Approved Phase 3 835-31-4 4436
26
Pseudoephedrine Approved Phase 3 90-82-4 7028
27
Cetirizine Approved Phase 3 83881-51-0 2678
28 Adrenergic Agents Phase 3
29 Adrenergic Agonists Phase 3
30 Adrenergic alpha-Agonists Phase 3
31 Antipruritics Phase 3,Phase 2
32 Dermatologic Agents Phase 3,Phase 2
33 Nasal Decongestants Phase 3
34 Respiratory System Agents Phase 3
35 Vasoconstrictor Agents Phase 3
36 Tetrahydrozoline Phase 2

Interventional clinical trials:

(show all 14)

# Name Status NCT ID Phase Drugs
1 A Study to Evaluate the Duration of LASTACAFT® in Acute Allergic Conjunctivitis Completed NCT01470118 Phase 4 alcaftadine 0.25% ophthalmic solution;olopatadine 0.2% ophthalmic solution;dextran 70 0.1%/hydroxypropyl methylcellulose 0.3%
2 A Study to Evaluate the Efficacy of Lastacaft® Compared to Pataday™ and Placebo in Patients With Acute Allergic Conjunctivitis Completed NCT01732757 Phase 4 Alcaftadine 0.25%;Olopatadine 0.2%;dextran 70 0.1%/hydroxypropyl methylcellulose 0.3%
3 Evaluation of the Onset and Duration of Action of Bepotastine Besilate Ophthalmic Solution in Acute Allergic Conjunctivitis Completed NCT00424398 Phase 2, Phase 3 Bepreve;Placebo;Bepotastine Besilate
4 Study of Olopatadine HCl Ophthalmic Solutions Compared to Vehicle Using the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis in Japanese Subjects Completed NCT00987272 Phase 3 Olopatadine Hydrochloride Ophthalmic Solution, 0.2%;Olopatadine Hydrochloride Ophthalmic Solution, 0.1%;Olopatadine 0.2% Vehicle;Olopatadine 0.1% Vehicle
5 Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Acute Allergic Conjunctivitis. Completed NCT00770133 Phase 3 Ketotifen/naphazoline;Naphazoline;Ketotifen;Vehicle
6 Evaluation of Efficacy of Ophthalmic Solution in Induced Acute Allergic Conjunctivitis Completed NCT00241319 Phase 3 R89674 (generic name not yet established)
7 An Evaluation of the Onset and Duration of Action of AKF-1 Ophthalmic Solution in Treating Acute Allergic Conjunctivitis Completed NCT01561521 Phase 3 AKF-1;AKF-1;AKF-1
8 A Multi-Center, Evaluation of the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle Completed NCT01881113 Phase 3 AC-170 0.24%;AC-170 0%
9 A Single-Center,Evaluation of the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle Completed NCT01685242 Phase 3 AC-170 0.24%;AC-170 0%
10 Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Allergic Conjunctivitis. Completed NCT00769886 Phase 3 Ketotifen/naphazoline;Ketotifen;Naphazoline;Vehicle
11 A Multi-Center Study Evaluating the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle in the Conjunctival Allergen Challenge (CAC) Completed NCT01551056 Phase 3 AC-170 0.24%;AC-170 0%
12 Evaluation of Efficacy of Ophthalmic Solution in Induced Allergic Conjunctivitis Completed NCT00244543 Phase 3 R89674 (generic name not yet established)
13 Evaluation of the Safety and Efficacy of Ketotifen 4.0% Patch as Compared to Placebo Patch, Olopatadine 0.2% Ophthalmic Solution, and Artificial Tears in the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis Completed NCT00836485 Phase 2 Ketotifen 4.0% Patch;Placebo;Olopatadine 0.2%;Artificial tears
14 A Study of ADX-102 in Subjects With Allergic Conjunctivitis Completed NCT03012165 Phase 2 ADX-102 Ophthalmic Drops (0.5%);ADX-102 Ophthalmic Drops (0.1%);Vehicle of ADX-102 Ophthalmic Drops

Search NIH Clinical Center for Angelucci's Syndrome

Genetic Tests for Angelucci's Syndrome

Anatomical Context for Angelucci's Syndrome

MalaCards organs/tissues related to Angelucci's Syndrome:

38
Eye

Publications for Angelucci's Syndrome

Variations for Angelucci's Syndrome

Expression for Angelucci's Syndrome

Search GEO for disease gene expression data for Angelucci's Syndrome.

Pathways for Angelucci's Syndrome

GO Terms for Angelucci's Syndrome

Sources for Angelucci's Syndrome

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....